RHAPSIDO

Product NDC
0078-1483
Requested package NDC
0078-1483-92
11-digit product format
000781483
Labeler code
0078
Product ID
0078-1483_03fb4b82-836d-4847-a9b5-e5695da55c1c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
remibrutinib
Dosage form
TABLET
Route
ORAL
Labeler
Novartis Pharmaceuticals Corporation
Application
NDA218436
Marketing category
NDA
Marketing start
2025-09-30
Substance
REMIBRUTINIB
Active strength
25 mg/1
Pharmacologic classes
Bruton's Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N218436-001RHAPSIDOREMIBRUTINIB25MGTABLET / ORALRLD, RS2025-09-30

Orange Book patents#

Current patent rows page 1 of 1 · 5 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N218436-001104576472034-11-13U-42802025-10-21
N218436-00195120842034-11-13Drug substance, Drug product2025-10-21
N218436-001124198892043-01-19U-42812025-10-21
N218436-001127519492043-12-09U-4611Drug substance, Drug product2026-10-13
N218436-001127519492043-12-09U-4612Drug substance, Drug product2026-10-13

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 2 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
N218436-001I-10022029-10-06
N218436-001NCE2030-09-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N218436-001RHAPSIDO25MGTABLET / ORALRLD, RS2025-09-30d4dbc9d85df4…
2026-10-15 13:18:302026-09N218436-001RHAPSIDO25MGTABLET / ORALRLD, RS2025-09-30c2088c7a36db…
2026-09-14 22:38:342026-08N218436-001RHAPSIDO25MGTABLET / ORALRLD, RS2025-09-3084e616aacf4f…
2026-08-18 06:07:402026-07N218436-001RHAPSIDO25MGTABLET / ORALRLD, RS2025-09-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N218436-001RHAPSIDO25MGTABLET / ORALRLD, RS2025-09-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218436-001RHAPSIDO25MGTABLET / ORALRLD, RS2025-09-3031067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N218436-001RHAPSIDO25MGTABLET / ORALRLD, RS2025-09-30a50c72e98297…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-11-14 07:37:172026-10N218436-001104576472034-11-13U-42802025-10-21d4dbc9d85df4…
2026-11-14 07:37:172026-10N218436-00195120842034-11-13Drug substance, Drug product2025-10-21d4dbc9d85df4…
2026-11-14 07:37:172026-10N218436-001124198892043-01-19U-42812025-10-21d4dbc9d85df4…
2026-11-14 07:37:172026-10N218436-001127519492043-12-09U-4611Drug substance, Drug product2026-10-13d4dbc9d85df4…
2026-11-14 07:37:172026-10N218436-001127519492043-12-09U-4612Drug substance, Drug product2026-10-13d4dbc9d85df4…
2026-10-15 13:18:302026-09N218436-001104576472034-11-13U-42802025-10-21c2088c7a36db…
2026-10-15 13:18:302026-09N218436-00195120842034-11-13Drug substance, Drug product2025-10-21c2088c7a36db…
2026-10-15 13:18:302026-09N218436-001124198892043-01-19U-42812025-10-21c2088c7a36db…
2026-09-14 22:38:342026-08N218436-001104576472034-11-13U-42802025-10-2184e616aacf4f…
2026-09-14 22:38:342026-08N218436-00195120842034-11-13Drug substance, Drug product2025-10-2184e616aacf4f…
2026-09-14 22:38:342026-08N218436-001124198892043-01-19U-42812025-10-2184e616aacf4f…
2026-08-18 06:07:402026-07N218436-001104576472034-11-13U-42802025-10-21caaa826d4ba7…
2026-08-18 06:07:402026-07N218436-00195120842034-11-13Drug substance, Drug product2025-10-21caaa826d4ba7…
2026-08-18 06:07:402026-07N218436-001124198892043-01-19U-42812025-10-21caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N218436-001104576472034-11-13U-42802025-10-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N218436-00195120842034-11-13Drug substance, Drug product2025-10-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02N218436-001124198892043-01-20U-42812025-10-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218436-001104576472034-11-13U-42802025-10-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218436-00195120842034-11-13Drug substance, Drug product2025-10-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218436-001124198892043-01-20U-42812025-10-2131067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N218436-001104576472034-11-13U-42802025-10-21a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N218436-00195120842034-11-13Drug substance, Drug product2025-10-21a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N218436-001124198892043-01-19U-42812025-10-21a50c72e98297…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-11-14 07:37:172026-10N218436-001I-10022029-10-06d4dbc9d85df4…
2026-11-14 07:37:172026-10N218436-001NCE2030-09-30d4dbc9d85df4…
2026-10-15 13:18:302026-09N218436-001NCE2030-09-30c2088c7a36db…
2026-09-14 22:38:342026-08N218436-001NCE2030-09-3084e616aacf4f…
2026-08-18 06:07:402026-07N218436-001NCE2030-09-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N218436-001NCE2030-09-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N218436-001NCE2030-09-3031067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N218436-001NCE2030-09-30a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
RHAPSIDO
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
REMIBRUTINIB25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
I7MVZ8HDNUInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2724392Internal RxNorm lookup
2724398Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e5e89bff-6ced-4165-acc5-fb13136b3a3dAvailable on FDA.report

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0078-1483-20RHAPSIDO60 in 1 BOTTLETABLET602
0078-1483-92RHAPSIDO30 in 1 BOTTLETABLET302
0078-1483-92RHAPSIDO2 in 1 CARTONTABLET22
0078-1483-93RHAPSIDO30 in 1 BOTTLETABLET302

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0078-1483-20EA - Each0078-148316d7ab04-bb1c-43cb-95ee-50d7a266620a12025-11-13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RHAPSIDOREMIBRUTINIBNovartis Pharmaceuticals Corporatione5e89bff-6ced-4165-acc5-fb13136b3a3d2026-10-06Warnings, Adverse reactionsExact identifier
application applno (NDA): 218436
application number: NDA218436
ndc (package): 0078-1483-92
ndc (product): 0078-1483
ndc11 (package): 00078148392

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2724392remibrutinib 25 MG Oral TabletPSNe5e89bff-6ced-4165-acc5-fb13136b3a3d2
2724398Rhapsido 25 MG Oral TabletPSNe5e89bff-6ced-4165-acc5-fb13136b3a3d2
2724398remibrutinib 25 MG Oral Tablet [Rhapsido]SBDe5e89bff-6ced-4165-acc5-fb13136b3a3d2
2724392remibrutinib 25 MG Oral TabletSCDe5e89bff-6ced-4165-acc5-fb13136b3a3d2
2724398Rhapsido 25 MG Oral TabletSYe5e89bff-6ced-4165-acc5-fb13136b3a3d2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0078-1483-92000781483922 BOTTLE in 1 CARTON (0078-1483-92) / 30 TABLET in 1 BOTTLE2 bottle2025-09-30YesNoCurrent